Advertise on podcast: The Dr. Geo Prostate Podcast

In this episode, Dr. Geo is joined by Dr. Steven Freeland to discuss the powerful intersection of urologic oncology and metabolic health. Dr. Freeland shares groundbreaking research on how dietary interventions—specifically low-carbohydrate protocols—can slow prostate cancer progression and counteract the metabolic damage caused by standard treatments like Androgen Deprivation Therapy (ADT). In This Episode, You’ll Learn:The Metabolic Growth Signal: Why insulin and Insulin-like Growth Factor 1 (IGF-1) are considered "fuel" for prostate cancer cells and how reducing sugar can starve that signal.The 20-Gram Protocol: Insights from Dr. Freeland’s study on ultra-low-carb diets, where participants saw a 20-pound weight loss and a significant slowing of PSA doubling time.Combatting ADT Side Effects: How a metabolic approach can improve insulin resistance by 30% and surprisingly help preserve bone density during hormone therapy.The "Slim-Fat" Reality: Why your BMI might be normal, but your visceral fat (adiposity) could still be driving inflammation and cancer growth.Clinical Markers to Watch: Why patients should ask about HOMA-IR (Insulin Resistance) and Hemoglobin A1C rather than just focusing on PSA alone. Key Quotes from the Episode:"Lifestyle intervention isn't alternative medicine; it is metabolic medicine." — Dr. Steven Freeland"Cancers need the same nutrients the body needs to grow. If we're reducing pro-growth stimuli to the whole body through weight loss and low carbs, it makes sense we're reducing it to the cancer." — Dr. Steven FreelandResources & Links Mentioned:Dr. Steven Freeland: Cedars-Sinai Faculty ProfileResearch Paper: Ultra-low carbohydrate diet and prostate cancer progression (referenced as the "20-gram study").Recommended Diet Protocol: Induction Phase Atkins (as used in the clinical trials).Clinical Markers: * HOMA-IR: (Fasting Insulin $\times$ Fasting Glucose) / 405 (or 22.5 in SI units).Hemoglobin A1C: A 90-day average of blood sugar levels.Wearables: Fitbit, Oura Ring, and Whoop (discussed in the context of tracking "active steps" and sleep quality). Episode Breakdown by Timestamp:[07:35] Breaking down the 20-gram carbohydrate trial and patient adherence.[13:45] The impact of...

Is the biopsy needle more dangerous than the cancer itself? In this episode, Dr. Geo sits down with Dr. Mark Emberton, Dean of Medical Sciences at UCL and a global leader in urologic oncology. We dive deep into the "See and Treat" revolution—a massive shift in prostate cancer care that moves away from "blind" invasive biopsies toward precision imaging like MRI and PSMA PET scans. Dr. Emberton explains why many prostate cancers found through traditional methods are "biological non-events" that never needed treatment, and how younger men (ages 40-50) can better navigate their diagnosis. We also discuss the future of focal therapy, the role of AI in radiology, and the groundbreaking "Transform" study that aims to change prostate screening forever. WHAT YOU'LL LEARN IN THIS EPISODE: ✅ Why a normal MRI (PI-RADS 1-2) might mean you can skip the biopsy entirely. ✅ The difference between "visible" tumors on imaging vs. microscopic disease. ✅ How PSA density acts as the crucial "tie-breaker" for indeterminate results. ✅ The future of "See and Treat": Targeting lesions while avoiding surgery side effects. ✅ Why tumor location (Anterior vs. Posterior) changes your treatment options. ✅ How AI and new magnets are making MRI screening cheaper and faster. 🕒 EPISODE TIMESTAMPS: 00:00 – The dangers of the biopsy needle 02:45 – Innovation in urologic oncology 06:45 – Rising cancer rates in younger men 10:15 – How MRI prevents unnecessary biopsies 12:30 – The PI-RADS "Traffic Light" system 13:45 – PSA Density: The diagnostic tie-breaker 16:30 – Diagnosing without a biopsy 21:00 – AI's role in faster, cheaper MRIs 26:45 – Visible vs. Invisible Cancer: What matters? 35:30 – The "Transform" Study & global screening 42:45 – PSMA PET Scans: Pre-biopsy utility 48:00 – Focal Therapy: Saving the "clockwork" 56:45 – Why tumor location (Anterior) matters 58:30 – Lifestyle and the "Teachable Moment" 01:03:30 – Final advice for patients and policy Connect with Dr. Mark Emberton: UCL Profile: https://profiles.ucl.ac.uk/mark-emberton ___________________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV ___________________________________ 💪 Exclusive Membership Want deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. → https://drgeo.com/membership ___________________________________ 📌 Follow and Connect 📺 YouTube → Dr. Geo Prostate Podcast — https://www.youtube.com/@DrGeoProstatePodcast 🎧 All Episodes → Captivate.fm Archive — https://dr-geo-prostate-podcast.captivate.fm 📸 Instagram → https://bit.ly/DRGEO-INSTA-YT 📘 Facebook → https://bit.ly/POD-FB-DrGeo 💼 LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT 🛒 Supplements → XY Wellness https://bit.ly/3uJPC7Z | Mr. Happy https://bit.ly/3TE7tWE 🌐 DrGeo.com Website → https://bit.ly/43khht0 ___________________________________ 📣 Hashtags #DrGeoProstatePodcast #ProstateHealth #ProstateCancer #MensHealth #IntegrativeUrology #Urology ___________________________________ ⚠️ Disclaimer This podcast is for educational purposes only and not medical advice. The views expressed are Dr. Geo’s and not those of his employer(s) or affiliated organizations. Use of this content is at your own risk. Geovanni Espinosa, N.D., assumes no liability for direct...

If you’re 55, 60, 65+ and dealing with low energy, low libido, ED, or you’ve been told testosterone therapy (TRT) is dangerous for prostate cancer—this episode is for you. Dr. Geo sits down with Dr. Abraham Morgentaler (Harvard-trained), founder of the first comprehensive Men’s Health Center in the U.S., co-founder of the Androgen Society, author of the bestseller Testosterone for Life, and winner of the 2024 Grandmaster in Testosterone Award. In this conversation, Dr. Morgentaler explains how the old “testosterone causes prostate cancer” dogma took hold, why it’s being challenged, and what men should understand today about: ✅ TRT and prostate cancer (past, present, and what’s changing) ✅ Why FREE testosterone matters more than total testosterone for symptoms ✅ The importance of listening to patient symptoms, not just “a number” ✅ Testosterone options: injections, gels/creams, pellets, oral testosterone ✅ What men should ask their doctor if they have low testosterone, active surveillance, or history of prostate cancer treatment This episode is educational and designed to help you walk into your next doctor’s visit with better questions and clearer understanding. ⏱️ CHAPTERS 00:00 — TRT + prostate cancer: the myth that won’t die 01:00 — Who is Dr. Abraham Morgentaler (why he matters) 04:00 — The Harvard lizard lab: how testosterone shaped his thinking 10:00 — Pre-Viagra era + why he started testing testosterone in men 18:00 — The turning point: finding prostate cancer in men with low T 21:00 — Where the dogma came from (Huggins) + why it stuck 27:00 — Why younger men may be seeing lower testosterone (obesity, plastics, more) 34:00 — Testosterone in advanced/metastatic prostate cancer: real cases + quality of life 40:00 — BAT explained: bipolar androgen therapy (high/low testosterone cycling) 45:00 — What patients should do today (TRT after treatment, ADT tradeoffs) 51:00 — The “twin” story: why stopping TRT often makes no sense 53:00 — Free testosterone vs total testosterone (what to focus on) 01:02:00 — TRT options: injections vs gels vs pellets vs oral 01:08:00 — Where to find Dr. Morgentaler + final takeaways 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet → https://bit.ly/3TVehAxAG1 by Athletic Greens → https://bit.ly/3mA2tVV 💪 Exclusive Membership Unlock curated transcripts, detailed show notes, expert resources, and perks. Join here → https://drgeo.com/membership 📌 Follow and Connect 📺 YouTube → Dr. Geo Prostate Podcast — / @drgeoprostatepodcast 🎧 All Episodes → https://dr-geo-prostate-podcast.captivate.fm/ 📸 Instagram → https://bit.ly/DRGEO-INSTA-YT 📘 Facebook → https://bit.ly/POD-FB-DrGeo 💼 LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT 🛒 Supplements → XY Wellness https://bit.ly/3uJPC7Z | Mr. Happy https://bit.ly/3TE7tWE 🌐 DrGeo.com Website → https://bit.ly/43khht0 📣 Hashtags #DrGeoProstatePodcast #ProstateCancer #ProstateHealth #MensHealth #IntegrativeUrology #Testosterone #TRT #ProstateCancer #LowTestosterone #MensHealth #ProstateHealth #DrGeo #AbrahamMorgentaler #AndrogenSociety #FreeTestosterone #ErectileDysfunction #HormoneHealth #HealthyAging #TestosteroneTherapy #Urology #MaleHormones #SexualHealth #ActiveSurveillance #ADT #BipolarAndrogenTherapy ⚠️ Disclaimer This video is for educational purposes only and not medical advice. Always consult with a qualified healthcare provider. Geovanni Espinosa, N.D., assumes no liability for outcomes based on this content.

If you’re a man in your 50s, 60s, or 70s waking up at night to pee, planning your day around bathroom access, or quietly worrying about erections and testosterone, this episode is for you. Dr. Geo sits down with Dr. Ravi Munver (Hackensack University Medical Center) to break down what’s actually driving urinary symptoms, how to tell “prostate vs bladder,” when waiting too long can permanently weaken your bladder, and how today’s BPH procedures compare—especially Aquablation (high-pressure, room-temperature waterjet therapy). What you’ll learn in this episode • Why BPH symptoms can start earlier than most men think (and why more men are finally talking about it) • Why prostate size does NOT equal symptom severity (big prostate ≠ big problem… always) • How to distinguish “prostate obstruction” vs overactive bladder—and why you can’t reliably do this without proper testing • The “danger zone”: when untreated obstruction can lead to a weakened/crippled bladder • Medication options: what each class does, who it’s for, and the most common side effects • The full “toolbox” of procedures—from office-based options to the most durable surgical solutions • Why Aquablation is changing the conversation (symptom relief + low sexual side effects + broad size range) Episode chapters (timestamps) 00:00:00 00:02:00 Why younger men are showing up with urinary symptoms Prostate growth patterns (growth early, pause, then growth again in the 40s); increased awareness, openness, and access to information. 00:07:00 “Blame the organ you have” — prostate vs overactive bladder Why symptoms overlap; why only a clinician can truly differentiate causes. 00:10:00 When should a man see a urologist? When symptoms interfere with life (work, travel, sleep). The real issue is often difficulty returning to sleep. 00:13:00 The risk of waiting: bladder decompensation How long-term obstruction can lead to a weakened bladder and urinary retention. 00:18:00 The holistic patient scenario + why objective testing matters Why symptoms can “seem better” while retention worsens; importance of measuring PVR and other tests. 00:21:00 Medications for BPH—pros/cons • Alpha blockers: tamsulosin (Flomax), alfuzosin, silodosin (Rapaflo) • 5-alpha reductase inhibitors: finasteride, dutasteride • Tadalafil (Cialis) daily 5 mg: dual benefits for BPH + erectile function 00:31:00 The modern BPH procedure toolbox TURP as the historical “gold standard,” plus lasers, robotic options, office-based procedures, and newer technologies. 00:36:00 What men care about most when choosing a procedure Incontinence risk, erectile dysfunction risk, ejaculatory changes, irritative symptoms, and durability/retreatment rates. 00:38:00 Robotic Simple Prostatectomy — what “simple” actually means Removing the obstructing inner tissue while leaving the capsule; major symptom relief for large prostates, with tradeoffs (especially ejaculation). 00:43:00Aquablation explained (high-pressure water therapy) Image-guided treatment planning + robotic waterjet tissue removal with minimal thermal damage. 00:48:00 Durability and size range Discussion of longer-term data vs TURP and why Aquablation can treat very large prostates. 00:51:00 If Aquablation isn’t available—what’s next best? How options shift based on prostate size and the priority to preserve ejaculation vs maximize durability. 00:54:00 Final guidance + where to find Dr. Munver Individualized care; find a urologist who can offer a broad set of options. ___________________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens

🔹 Register FREE for the Prostate Summit 2.0: 👉 https://drtalks.com/summit/prostate-cancer/?oid=104&ref=3642&uid=918 In this special session from the upcoming Prostate Summit 2.0, Dr. Eric Zielinski sits down with Dr. Geo for a rare, vulnerable and informative conversation about the why behind his life’s work in prostate cancer care. Key Points The emotional and spiritual side of working with thousands of menWhy your why matters more than the diet, protocol, or treatment choiceThe 3 buckets of prostate cancer and why care must be personalizedHis 4 pillars of healing: lifestyle, nutrition, fitness, and stress masteryHow fasting, cruciferous veggies, mushrooms, herbs, and targeted nutraceuticals help build resilienceWhy exercise is non-negotiable, and how sitting all day harms prostate and metabolic health This episode blends heart, science, and practical strategy to help men live longer and better with prostate cancer. Chapters 00:00 – Intro 02:00 – The “why” behind Dr. Geo’s work 07:00 – A powerful patient story & legacy 12:00 – The 3 buckets of prostate cancer 18:00 – Food, fasting & “It Days” 23:00 – Exercise, sitting & movement 32:00 – Mushrooms, herbs & targeted nutraceuticals From the upcoming Prostate Summit 2.0 🔶 FREE EVENT – PROSTATE SUMMIT 2. 👉 Register here: ⬇️👉 https://drtalks.com/summit/prostate-cancer/?oid=104&ref=3642&uid=918 ___________________________________ 🌱 Partner OffersProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV ___________________________________ 💪 Exclusive MembershipWant deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. → https://drgeo.com/membership ___________________________________ 📌 Follow and Connect📺 YouTube → Dr. Geo Prostate Podcast — https://www.youtube.com/@DrGeoProstatePodcast 🎧 All Episodes → Captivate.fm Archive — https://dr-geo-prostate-podcast.captivate.fm 📸 Instagram → https://bit.ly/DRGEO-INSTA-YT 📘 Facebook → https://bit.ly/POD-FB-DrGeo 💼 LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT 🛒 Supplements → XY Wellness https://bit.ly/3uJPC7Z | Mr. Happya...

Dr. Geo and Dr. Robert Caruso dive deep into what really causes urinary symptoms in men—and why prostate size alone doesn’t tell the full story. Dr. Caruso shares how his “blue zone” Italian upbringing, his 98-year-old mother, and even a family story involving a bear shaped his holistic view of urology, where diet, movement, spine health, constipation, and sleep apnea all matter. From there, they walk through medications (alpha-blockers, 5-alpha-reductase inhibitors, daily tadalafil) and when each actually makes sense, including surprising cardiovascular and nocturia benefits of PDE5 inhibitors. The conversation then shifts to procedures: bipolar TURP vs classic TURP, and in-office options like UroLift, Rezūm steam therapy, and the newer iTind device—who they’re for, how they’re done, and what to expect for recovery, ejaculation, and long-term results. By the end, you’ll know what questions to bring to your urologist, how to think beyond “just the prostate,” and when vapor therapy or other minimally invasive treatments may be the right next step for your BPH. Time-Stamped Highlights 00:00 – Why surgery isn’t the only answer for BPH-Dr. Geo introduces Dr. Caruso and frames the episode around minimally invasive, real-world solutions for urinary symptoms. 05:00 – Blue-zone lifestyle, Italian roots, and holistic urology-Dr. Caruso’s upbringing, his 98-year-old mother, and how growing food, movement, and nature shape his approach to men’s health. 15:00 – It’s not “just the prostate”: spine, sleep, and metabolism-How back and neck issues, constipation, diabetes, and sleep apnea can drive frequency and nocturia just as much as gland size. 25:00 – Meds that do more: tadalafil, alpha-blockers, and 5-ARIs-When daily tadalafil can help erections, BPH, and nocturia; who might benefit from alpha-blockers or finasteride/dutasteride—and who probably shouldn’t. 35:00 – From TURP to in-office options: choosing the right procedure-Bipolar TURP for large prostates and median lobes vs. office-based UroLift, Rezūm steam therapy, and iTind—what they are, how long they last, and what to ask your urologist about ejaculation, catheters, and recovery. ________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet → https://bit.ly/3TVehAx AG1 by Athletic Greens → https://bit.ly/3mA2tVV 💪 Exclusive Membership Unlock curated transcripts, detailed show notes, expert resources, and perks. Join here → https://drgeo.com/membership 📌 Follow and Connect YouTube → https://www.youtube.com/@DrGeoProstatePodcast All Podcast Episodes → https://dr-geo-prostate-podcast.captivate.fm Instagram → https://bit.ly/DRGEO-INSTA-YT Facebook → https://bit.ly/POD-FB-DrGeo LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT XY Wellness Supplements → https://bit.ly/3uJPC7Z Mr. Happy → https://bit.ly/3TE7tWE Website → https://bit.ly/43khht0 📣 Hashtags #EnlargedProstate #ProstateHealth #MensHealth #DrGeoEspinosa #ProstateProblems #BPH #ProstateEnlargement #UrinaryHealth #IntegrativeUrology #ProstateCancerAwareness ⚠️ Disclaimer This episode is for educational purposes only and not medical advice. Always consult with a qualified healthcare provider. Geovanni Espinosa, N.D., assumes no liability for outcomes based on this content.

Is a big prostate really dangerous? Does it mean prostate cancer—or explain why you’re waking up at night to urinate? Not always. In this upgraded replay, Dr. Geo breaks down the real story behind prostate enlargement why size isn’t always the issue, how bladder and nerve health factor in, and what questions to ask your doctor before starting medication or considering surgery. 🎯 You’ll Learn ✅ Why prostate size isn’t always the cause of urinary problems
 ✅ How the bladder and nerves affect flow and frequency 
✅ When drugs like Finasteride and Dutasteride are unnecessary
 ✅ Why an enlarged prostate ≠ prostate cancer 
✅ Smart testing options to avoid unnecessary biopsies ⏱ Chapters 00:00 Introduction — How dangerous is an enlarged prostate?
 00:45 Normal vs Enlarged Prostate — Walnut vs Orange size explained
 01:20 When Size Doesn’t Matter — Obstruction without enlargement
 02:00 The Morning Stream Myth — Why slow flow at dawn isn’t always serious
 03:00 Bladder-Prostate Synergy — The teamwork behind healthy urination
 04:15 Medication Pitfalls — Finasteride & Dutasteride explained
 05:30 Hair Loss & Hormones — Side effects of prostate drugs
 06:00 Enlarged Prostate ≠ Cancer — Clearing up the myth
 07:00 When It Can Be a Problem — Nerve compression & PAE treatment
 08:00 Smarter Testing — ExoDx urine test vs PSA
 08:45 Questions to Ask Your Urologist
 09:30 Closing Thoughts — Live stronger, longer, and better ________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet → https://bit.ly/3TVehAx AG1 by Athletic Greens → https://bit.ly/3mA2tVV 💪 Exclusive Membership Unlock curated transcripts, detailed show notes, expert resources, and perks. Join here → https://drgeo.com/membership 📌 Follow and Connect YouTube → https://www.youtube.com/@DrGeoProstatePodcast All Podcast Episodes → https://dr-geo-prostate-podcast.captivate.fm Instagram → https://bit.ly/DRGEO-INSTA-YT Facebook → https://bit.ly/POD-FB-DrGeo LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT XY Wellness Supplements → https://bit.ly/3uJPC7Z Mr. Happy → https://bit.ly/3TE7tWE Website → https://bit.ly/43khht0 📣 Hashtags #EnlargedProstate #ProstateHealth #MensHealth #DrGeoEspinosa #ProstateProblems #BPH #ProstateEnlargement #UrinaryHealth #IntegrativeUrology #ProstateCancerAwareness ⚠️ Disclaimer This episode is for educational purposes only and not medical advice. Always consult with a qualified healthcare provider. Geovanni Espinosa, N.D., assumes no liability for outcomes based on this content.

Dr. Geo speaks with cancer immunologist Matthew Halpert, PhD about Immunocine, a dendritic-cell platform that “double-loads” patient-specific tumor signals to trigger a strong, physiologic immune response. Discussion includes mechanism, prostate cancer cases, how it can complement ADT and focal radiation, eligibility, workflow, and access. Chapters 00:00 How the Immune System Fights Prostate Cancer 02:00 Why dendritic cells matter; generals vs NK/T “soldiers” 07:00 The “double-loading” breakthrough and fail-safe concept 14:00 Trials in difficult cancers; safety and early signals 18:00 Prostate cases: CRPC responses; lesions regressing 22:00 Combining with ADT and focal radiation; timing 27:00 Critical need for viable tissue; preservation tips 34:00 Patient journey: review → tissue + apheresis → 3 doses/6 weeks 41:00 Peri-lymphatic delivery; what patients feel; follow-up/boosts 49:00 Cost, access, insurance help; foundations; closing takeaways Key Takeaways Dendritic cells orchestrate immunity; NK/T cells execute.Precision double-loading overcomes a built-in fail-safe to amplify activation.Tissue access and preservation are essential for a broad, personalized target set.Pragmatic combination care: ADT and selective radiation can create a therapeutic window and enhance antigen presentation. ________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet → https://bit.ly/3TVehAx AG1 by Athletic Greens → https://bit.ly/3mA2tVV 💪 Exclusive Membership Unlock curated transcripts, detailed show notes, expert resources, and perks. Join here → https://drgeo.com/membership 📌 Follow and Connect YouTube → https://www.youtube.com/@DrGeoProstatePodcast All Podcast Episodes → https://dr-geo-prostate-podcast.captivate.fm Instagram → https://bit.ly/DRGEO-INSTA-YT Facebook → https://bit.ly/POD-FB-DrGeo LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT XY Wellness Supplements → https://bit.ly/3uJPC7Z Mr. Happy → https://bit.ly/3TE7tWE Website → https://bit.ly/43khht0 📣 Hashtags #DrGeoProstatePodcast #ProstateCancer #ProstateHealth #MensHealth #IntegrativeUrology #SBRT #Oligometastatic #RadiationOncology #PSMAPET #ADT ⚠️ Disclaimer This episode is for educational purposes only and not medical advice. Always consult with a qualified healthcare provider. Geovanni Espinosa, N.D., assumes no liability for outcomes based on this content.

AI has existed for decades, but modern deep learning is finally delivering precision decisions in clinic. Dr. Spratt details how ArteraAI’s predictive biomarker—validated on long-term randomized data—can spare roughly two-thirds of eligible men from ADT without compromising outcomes. We unpack ADT’s quality-of-life trade-offs, practical training and nutrition strategies to preserve muscle, and where AI is headed next (post-surgery models, higher-risk disease). You’ll also hear a clear framework for shared decision-making so men are treated as people, not just numbers. Key Points✅ AI meets prostate cancer. ArteraAI, developed by Dr. Daniel Spratt’s team, is now part of the NCCN guidelines—helping doctors know which patients truly benefit from hormone therapy. ✅ Two-thirds can skip ADT. Long-term data from the RTOG 9408 trial show most men can avoid the side effects of hormone therapy without affecting outcomes. ✅ Quality of life first. Treatments should improve survival or well-being—if they don’t, they shouldn’t be used. ✅ Lifestyle still matters. Exercise, protein, and resistance training help men on ADT preserve muscle and energy. ✅ The future is personalized. New AI models will soon guide therapy for higher-risk patients and integrate full-body health data for truly tailored care. ⏱️ Time-Stamped Highlights00:00 – Why AI in prostate cancer now? From buzzword to bedside with ArteraAI.01:30 – Deep learning vs. “human-defined” inputs; beyond Gleason to hundreds of slide features.03:10 – Landmark validation: RTOG 9408 and how the model predicts who benefits from ADT.05:00 – ADT trade-offs: longevity vs. libido, energy, bone/muscle; treat only if it improves life or survival.07:15 – “Exercise is medicine”: the 10-minute rule, protein targets, and resistance training on ADT.09:00 – Current indication: primarily intermediate-risk (Gleason 7) men receiving radiation.10:45 – What’s next: models for higher-risk and post-prostatectomy patients; shorter-course ADT questions.13:00 – “Black box” & explainability: why robust external validation matters for trust.15:10 – Access & coverage: ordering via online portal; CMS coverage; what patients can ask their doctors.17:20 – Shared decision-making: reduce PSA anxiety; treat the person, not the number. ___________________________________ 🌱 Partner OffersProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV ___________________________________ 💪 Exclusive MembershipWant deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. →...

Can high-precision radiation change how we treat metastatic prostate cancer? In this episode, I’m joined by Ronald C. Chen, MD, MPH—radiation oncologist, national guideline author (AUA/ASCO), and clinical-trial leader with 170+ publications—to unpack stereotactic body radiation therapy (SBRT) for disease that has spread to lymph nodes, bones, and beyond. We get practical about who benefits, where SBRT shines, and how to balance treatment intensity with quality of life. SBRT offers highly focused, short-course radiation that can control limited (“oligo-”) metastatic prostate cancer and delay systemic therapy for many men. Dr. Chen explains when to treat individual nodes/bone lesions versus comprehensive nodal fields, how anatomy determines dose/fraction choices (often 3–5 treatments), and why modern SBRT sometimes reduces the need for concurrent hormone therapy. We cover salvage options after prior radiation (brachytherapy seeds, HIFU, cryo, repeat SBRT, or salvage prostatectomy), the role and limits of PSMA PET, fracture risk and bone health (DEXA), and the evolving data—including the large NRG-GU013 trial—for higher-risk disease. Throughout, we emphasize shared decision-making, realistic expectations, and considering clinical trials when data are evolving. 00:00 – Can SBRT change metastatic prostate cancer care? Meet Dr. Ron Chen. 01:00 – Disclaimer: Views are Dr. Geo’s and guests’—independent of NYU Langone. 07:00 – Recurrence scenarios: prostate-only, nodal, or bone/other; why catching early matters. 12:00 – Five salvage options after prostate radiation: seeds (brachytherapy), HIFU, cryo, SBRT (focal or whole-gland), or salvage prostatectomy. 19:00 – Nodal relapse: treat all pelvic nodes + ADT ± abiraterone vs. SBRT to a few nodes only—how patient priorities drive the plan. 26:30 – Oligometastasis: SBRT alone can control disease for many men ~2+ years on average, delaying hormones. 30:00 – Fractions: why 3–5 treatments is typical and how adjacent bowel/organ anatomy sets the pace. 31:00 – SBRT in 2 fractions for select primary cases looks promising; high-risk SBRT under study (NRG-GU013). 37:00 – Bone mets: SBRT preferred; understanding fracture risk (tumor size, dose, shrinkage). 40:00 – DEXA before ADT; spine SBRT can spare the spinal cord with modern planning. 48:00 – Clavicle/hilar nodes: SBRT near lung/heart/esophagus—safe with careful dose constraints. 56:00 – Why clinical trials matter for “how long on hormones?” and other open questions. 57:00 – Soft-tissue mets (liver/brain): SBRT can help, often alongside systemic therapy. 59:00 – Parting advice: early detection, close follow-up, and hopeful trajectory of care. ___________________________________ 🌱 Partner OffersProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and...

Is androgen deprivation therapy (ADT) always necessary when prostate cancer patients undergo radiation? And if so, for how long—six months, a year, two years? In this insightful conversation, Dr. Geo sits down with Dr. Nima Aghdam, radiation oncologist at NY CyberKnife and NYU Langone, to explore the evolving role of ADT in prostate cancer treatment. Dr. Aghdam shares his expertise on advanced radiation techniques like SBRT, personalized approaches to ADT duration, and the importance of lifestyle interventions. Together, they highlight how individualized care can improve survival, minimize side effects, and help men thrive beyond diagnosis. If you or a loved one are facing decisions about radiation and hormone therapy for prostate cancer, this episode offers clarity, evidence-based guidance, and hope. Radiation vs. Surgery: Both are highly effective; choice often comes down to quality-of-life goals and patient preference. Lymph Node Positive Disease: Options include focal SBRT or comprehensive external beam therapy; treatment decisions must balance efficacy and quality of life. Lifestyle’s Role: Exercise and nutrition create a “hostile microenvironment” for cancer, improving both survival and side-effect management. Radiation Innovations: From rectal spacers to fewer treatment sessions (trials reducing SBRT from five to two fractions), techniques continue to evolve. ADT Considerations: Historically prescribed for up to 24–36 months with radiation. New genomic and AI-based classifiers may allow some men to stop ADT earlier (6–12 months). Balancing survival benefits with quality of life is critical. PSA Anxiety: PSA fluctuations don’t always equate to recurrence or mortality. Context and long-term monitoring matter more than isolated numbers. Finding the Right Oncologist: Beyond equipment and technology, trust and honest communication with your doctor are essential. Timestamps00:00 – Introduction: Is ADT always necessary during radiation?05:00 – Radiation vs. surgery for localized and advanced prostate cancer.10:00 – Salvage options: what happens if radiation or surgery fails?13:00 – Treating prostate cancer with lymph node involvement.17:00 – Communicating metastasis risk and long-term outcomes to patients.18:30 – Lifestyle interventions as part of prostate cancer care.21:00 – Rectal spacers and preparation for SBRT.23:30 – Advances in SBRT: reducing from five fractions to two.25:30 – Understanding fractions, dosage, and radiation delivery.32:00 – Personalizing ADT: who benefits, and for how long?36:00 – Clinical trials on ADT duration (6, 12, 18, 24+ months).39:00 – Radiation’s long-lasting effects and how ADT fits in.42:00 – PSA recurrence vs. actual risk of mortality45:00 – Patient anxiety and the psychological impact of PSA testing.47:00 – Exercise and lifestyle: evidence for improved survival.49:00 – Supplements, PSA manipulation, and misinformation.51:00 – How to choose a reputable radiation oncologist.56:00 – Evolving evidence: are radiation-related risks lower today?58:00 – Parting words: seeing prostate cancer as a chance for transformation. ___________________________________ 🌱 Partner OffersProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular...

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I’m joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections. Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today’s standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment. Time-Stamped Highlights 00:00 – Why fewer incisions + faster recovery are now real in prostate surgery 05:40 – Work–life changes that improved health (sleep, exercise, biking) 09:10 – Open vs. robotic: why reproducibility (teachability) matters 11:05 – Robotics adoption curve: from early resistance to mainstream 19:05 – Outcomes today: continence and erections after modern surgery 20:10 – “Yes, I’m a surgeon—and here’s my bias.” Radical honesty with patients 22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton 25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT 34:00 – Dexterity & visualization: why robots spare nerves with less trauma 35:10 – Real-time margin assessment during surgery to reduce positives 40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities 42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment 45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer 46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients) 49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential 52:30 – How to find Dr. Stifelman & closing advice ___________________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV ___________________________________ 💪 Exclusive Membership Want deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. → https://drgeo.com/membership ___________________________________ 📌 Follow and Connect 📺 YouTube → Dr. Geo Prostate Podcast — https://www.youtube.com/@DrGeoProstatePodcast 🎧 All Episodes → Captivate.fm Archive — https://dr-geo-prostate-podcast.captivate.fm 📸 Instagram → https://bit.ly/DRGEO-INSTA-YT 📘 Facebook → https://bit.ly/POD-FB-DrGeo 💼 LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT 🛒 Supplements → XY Wellness https://bit.ly/3uJPC7Z | Mr. Happy https://bit.ly/3TE7tWE 🌐 DrGeo.com Website → https://bit.ly/43khht0 ___________________________________ 📣 Hashtags #DrGeoProstatePodcast #ProstateHealth #ProstateCancer...

What if prostate cancer treatment weren’t months of daily radiation—but five ultra-precise sessions guided in real time by MRI? Today, Dr. Michael J. Zelefsky (Professor of Radiation Oncology, NYU Grossman School of Medicine) explains how MRI-LINAC and adaptive planning are redefining accuracy, reducing side effects, and personalizing care. A pioneer behind IMRT and image-guided radiotherapy, Dr. Zelefsky breaks down SBRT vs. IMRT, protons vs. photons, HDR brachytherapy, when to add hormone therapy, and how genomics + AI are shaping what’s next. In this conversation, Dr. Zelefsky charts the evolution from long-course radiation to short-course SBRT with outcomes comparable to 7–9 week regimens—thanks to precision imaging and planning. He clarifies where IMRT ends and SBRT begins, why protons haven’t shown superiority over photons in prostate cancer, and where HDR brachytherapy (Ir-192) shines—especially as a boost in higher-risk disease. We dig into dose equivalence (why 5×8 Gy can match ~80–90 Gy long-course), risk-based treatment + ADT duration, and how Decipher/Artera scores can refine decisions. Most exciting: MRI-LINAC with continuous motion monitoring keeps the prostate in a virtual “bullseye,” enabling whole-gland treatment with focal boosts today—and potentially true focal therapy tomorrow as biologic imaging and AI mature. Time-Stamped Highlights 00:00 – Welcome 02:00 – Why Dr. Zelefsky’s work is so respected; career arc and impact 04:00 – What changed: CT/MRI planning → 3D-CRT → IMRT → SBRT 12:45 – IMRT vs. SBRT: definitions, session counts, who gets what 19:10 – Energy sources overview: photons, protons, brachytherapy 20:30 – Protons vs. photons: evidence, indications, cost, access 24:00 – HDR brachytherapy (Ir-192) as a temporary “in-and-out” boost 28:00 – Dose logic: why 5×8 Gy (~40 Gy) ≈ long-course 80–90 Gy 29:30 – Risk groups (low/intermediate/high) and when ADT is crucial 33:00 – ADT durations (6–36 months): what trials actually showed 37:00 – Genomics (Decipher/Artera): resolving risk discrepancies 39:00 – What MRI-LINAC adds: real-time adaptive planning 43:00 – Continuous Motion Monitoring (CMM): beam stops if target moves 47:00 – Treat whole gland + boost the DIL (FLAME study approach) 49:00 – Toward focal therapy with better biologic imaging + AI 54:00 – How to choose: values, side-effects, lifestyle, comorbidities 01:01:00 – Final guidance: don’t be overwhelmed—multiple good option 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV 💪 Exclusive Membership Want deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. → a...

HIFU (high-intensity focused ultrasound) is one of the most talked-about focal therapies in prostate cancer—but who is it really right for? In this conversation, Dr. Matthew Cooperberg (UCSF)—a leading voice in urology, epidemiology, and integrative prostate cancer care—breaks down patient selection vs. energy modality, how modern imaging (MRI, fusion, RSI) drives precision, what genomics (e.g., Decipher) can and can’t tell us, and how salvage options compare after focal therapy vs. radiation. We also tackle lifestyle factors, trial design, and why midlife PSA screening (ideally modality) 05:10 – What “focal therapy” means (lesion-only, margin, hemi-ablation) + imaging progress 06:25 – Recurrence after focal therapy: targeting, dose, or biology? Follow-up biopsies 07:40 – Genomics (Decipher): predicting recurrence; how results change counseling 09:30 – Lifestyle & microenvironment: can diet/exercise influence outcomes? 11:00 – Salvage after focal vs. radiation: fibrosis, feasibility, quality of life 14:00 – Cryotherapy vs. HIFU: image guidance, control, and why HIFU advanced 16:00 – Imaging upgrades (MRI fusion, RSI, C-13 spectroscopy) and treatment constraints 17:00 – IRE (irreversible electroporation): role for apical tumors, early results 18:00 – TULSA, water/thermal concepts, focal radiation, partial prostatectomy: what’s known 20:00 – Smarter trials: active surveillance ± focal therapy for borderline cases 22:00 – The counseling hierarchy: decision first, technology second 24:30 – Proton vs. photon incentives; why advertising confuses choices 26:30 – UCSF’s program: mostly HIFU; where IRE fits; adding new machines prudently 28:30 – The real bottleneck: sub-millimeter targeting; AI-guided ablation future 33:00 – HIFU mechanics: probe size, apex/anterior reach, distance constraints 35:00 – “I want HIFU for Gleason 8”: agency, nuance, and when we advise against it 38:00 – A cautionary case: negative biopsy → later mets—what it teaches us 40:30 – Millennials, risk tolerance, and why PSA at 45–55 (1 is ideal) matters 44:00 – Growth vs. spread: which high-grade tumors can we treat focally? 46:00 – How low vs. high genomic scores tilt decisions (and their limits) 47:30 – Where to find Dr. Cooperberg + parting PSA advice ___________________________________ 🌱 Partner OffersProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV ___________________________________ 💪 Exclusive MembershipWant deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. →a href="https://drgeo.com/membership?utm_source=chatgpt.com" rel="noopener...

Can high-dose IV Vitamin C really support cancer treatment—even in men with prostate cancer? In this episode of the Dr. Geo Prostate Podcast, Dr. Geo welcomes Dr. Paul Anderson, one of the world’s leading voices in integrative oncology with 30+ years of clinical experience and NIH-funded cancer research. Together, they unpack how vitamin C works differently when taken orally versus intravenously, what the latest research shows about IV vitamin C, and how it may impact the tumor microenvironment and immune response. Listeners will also learn about practical approaches to integrative oncology, the role of detoxification and immune health, and what patients with advanced prostate cancer should know before seeking out IV vitamin C therapy. ✅ What You’ll Learn in This Episode: How oral vs. IV vitamin C behave differently in the bodyWhat the latest science says about IV vitamin C in cancer careWhy the tumor microenvironment matters for long-term outcomesHow IV vitamin C may support men with advanced prostate cancerSynergies with lifestyle therapies, immunotherapy, and sauna 💡 Don’t forget to subscribe, rate, and review the podcast! Every review helps us reach more men who want to thrive, not just survive. _________________________ 🌱 Partner Offers ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV 💪 Exclusive Membership Want deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. → https://drgeo.com/membership 📌 Follow and Connect 📺 YouTube → Dr. Geo Prostate Podcast / @drgeoprostatepodcast 🎧 Listen to All Episodes → https://dr-geo-prostate-podcast.captivate.fm/ _________________________ ⚠️ Disclaimer: This podcast is educational and not medical advice. Always consult your healthcare provider before making changes to your treatment.